ByTrending Posts
Can Pfizer’s 2025 Brand Launches Across Vaccines, Oncology,…
Global | January 2026 — Pfizer Inc. advanced its post-pandemic transformation in 2025 through a series of targeted…
Will Merck’s $9.2 Billion Acquisition of Cidara Therapeutics…
Rahway, NJ & San Diego, CA | January 2026 Merck & Co., Inc. has confirmed that its approximately…
Can Insilico Medicine’s Hong Kong IPO Signal a…
Hong Kong | January 4, 2026 Insilico Medicine, a China-based, AI-driven drug discovery company backed by Qiming Venture…
Is AI Now Shaping the Future of Biopharma…
Executive Summary A recent Endpoints Signal Pulse Report reveals that half of biopharma professionals now consider themselves heavy…
Is Butterfly Network Using AI and Handheld Imaging…
Executive Summary Butterfly Network is pioneering AI-enabled, handheld ultrasound devices designed to make imaging more accessible, affordable, and…
Is Canon Medical Systems Using AI to Transform…
Executive Summary Canon Medical Systems is advancing the integration of artificial intelligence, automated analytics, and cloud-enabled imaging solutions…
Is Siemens Healthineers Using AI to Transform Diagnostics,…
Executive Summary Siemens Healthineers, a global leader in medical technology, is accelerating the adoption of AI-driven solutions across…
Can GE Healthcare Integrate AI Across Imaging, Monitoring,…
Headline Summary GE Healthcare, a global leader in medical technology, is driving the next wave of healthcare innovation…
Is Philips Leveraging AI and Connected Care to…
Executive Summary Philips, a global leader in health technology, is accelerating the integration of artificial intelligence, advanced analytics,…
Trending Posts
Latest Stories
Can Unnatural Products and Novartis Unlock “Undruggable” Cardiovascular Targets with AI-Designed Macrocyclic Peptides?
Santa Cruz, Calif., February, 2026 — Unnatural Products, Inc. (UNP) today announced a research collaboration…
Can Foundation Medicine and Manifold Redefine Precision Oncology Through AI-Driven Genomic Analytics?
Are Foundation Medicine and Manifold Signaling the Next Evolution of AI-Integrated Oncology Intelligence? In a…
Can Generate Biomedicines—Backed by Amgen and Novartis—Redefine Biologics Discovery Through AI-Designed Protein Therapeutics?
Generate Biomedicines, Amgen and Novartis Signal Capital-Market Validation for AI-Driven Biologics Innovation The AI drug…
Can Insilico Medicine and China Medical System Accelerate AI-Discovered Drugs from Algorithm to Clinic?
Executive SummaryIn a strategic expansion of their collaboration in February 2026, Insilico Medicine and China…
Gallery
